Navigation Links
Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.
Date:5/24/2013

HAYWARD, Calif., May 24, 2013 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today reported Dr. Edward W. Knowlton has resigned as a member of the Company's Board of Directors effective immediately.  Dr. Knowlton is the founder of Thermage, the predecessor company to Solta Medical and had served as a director since 1996.

"On behalf of the entire Board of Directors, as well as our management team, I would like to thank Ed for his tireless dedication to our company and his numerous contributions," said Stephen J. Fanning , Chairman, President and CEO.  "Ed is a pioneer in the medical aesthetics industry having authored numerous patents in the field and written several scientific papers on plastic surgery.  We will miss his participation on our Board of Directors."

"Solta has emerged as the leading innovator in the medical aesthetics industry and is positioned to build returns for our shareholders," said Dr. Knowlton.  "After several years as a member of the Board, I've decided that now is an opportune time for me to leave my formal role with Solta.  As the Company's founder, Solta and the team will be always near and dear to me and they can always count on my help whenever I can be of assistance."

With Mr. Knowlton's resignation, Solta has seven directors.  The Board currently does not intend to add an eighth director.

About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative solutions with proven efficacy and safety backed by over 10 years of clinical study and research. The company offers aesthetic energy devices for skin resurfacing and rejuvenation, acne reduction, body contouring and skin tightening, as well as tools
'/>"/>

SOURCE Solta Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Edwards Lifesciences Chief Medical Officer to Keynote the Inaugural MedTech Cardio 2012 Conference at the MD&M Minneapolis Exposition and Conference
2. Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")
3. Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344
4. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
5. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
6. Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
7. Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors
8. Orthopaedic Synergy, Inc. Announces Key Additions to the Board of Directors
9. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
10. DxInsights Names Ethan K. Knowlden Executive Director
11. Andrew Love Joins The Female Health Company Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 3, 2015  Lightlake Therapeutics ... addiction treatments based on its expertise in opioid ... Lightlake,s partner for treating opioid overdose with intranasal ... New Drug Application (NDA) to the United States ... spray formulation of naloxone, a drug intended to ...
(Date:6/3/2015)... 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... license agreement with AbbVie (NYSE: ABBV ) to ... with Halozyme,s ENHANZE ™ platform. ... will receive an initial $23 million payment, followed ... each of up to nine collaboration targets. These ...
(Date:6/3/2015)... 2015  VA North Texas Health Care System ... vBloc, a technology-based, scientifically advanced weight loss therapy.  ... called the Maestro® Rechargeable System that intermittently blocks ... involving food intake and processing between the brain ... customizable to meet the needs of a patient,s ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 3Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 2Halozyme Enters Into Global Collaboration and Licensing Agreement With AbbVie 3VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 2VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 3
(Date:6/3/2015)... (PRWEB) June 03, 2015 The Canton ... transforms businesses with technology, announced today that Tim Dodge ... Mr. Dodge joins The Canton Group as ... of successful customer engagements. , Tim is a tech ... for a variety of technology companies. Before joining The ...
(Date:6/3/2015)... Seattle, WA (PRWEB) June 03, 2015 On ... for the majority of genetic drug sensitivity (pharmacogenetic) testing that ... expected to impact as many as 19 million of the ... special risk of costly and life-threatening adverse drug events.(1) Sadly, ... save Medicare millions. , Precision Medicine, the use of an ...
(Date:6/3/2015)... June 03, 2015 Horizon Blue Cross Blue ... Magazine as one of the nation’s top employers for diverse ... 6 among its national list of Best Places for Diverse ... the No. 1 Regional Company. This is the sixth ... MBA Magazine for its diverse workplace policies and programs. , ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 A group ... be honored with a Global Inspire Award at DIA’s ... the organization’s outstanding volunteers for their leadership, level of ... , The recipients of the Author(s) of ... of authors whose article has made a significant impact ...
(Date:6/3/2015)... Visual BI Solutions, a leader in ... launch of the second release of its successful ... Studio. The Design Studio EXtension suite allows customers ... into their dashboarding projects. , With the second ... adding key components for customers that are looking ...
Breaking Medicine News(10 mins):Health News:The Canton Group Appoints Tim Dodge as Chief Marketing Officer 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Authors Representing TransCelerate BioPharma Inc. to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 4Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 2Health News:Visual BI Launches Second Release for its Design Studio EXtensions (DSX) for SAP® BusinessObjects™ Design Studio 3
... Wednesday evening swayed to the tunes of catchy Bollywood ... awareness// that saw participation of over 10,000 sex workers ... a pair of black trousers, matching shirt and a ... Jalaile" to the delight of the mixed gathering of ...
... with gonorrhea is probably twice as likely to develop bladder ... results in the British Journal of Cancer, lead author David ... the statement based on case studies of around 51,000 American ... men suffering from gonorrhea. Results analyzed showed that ...
... the general public. This was revealed by a research conducted ... ,Among other reasons cited, drug overdose is said to ... ailments, homicides, suicides, cancer, and smoking. This study was conducted ... a researcher and an assistant professor at University of Colorado ...
... grown soy beans may prove to be successful in ... Tulane //University cancer researcher Matthew Burow. ,Burow ... ovarian and breast cancer tumors that are stimulated by ... growth of the tumors by interfering with the tumor’s ...
... emergency medical system in the national capital to help ... and thus reduce fatalities. ,"In collaboration with the ... system in Pune. Delhi will soon have the facility," ... of Indian Origin (AAPI), said Wednesday. ,Under this ...
... acclaimed as the "gold-standard" amongst researchers for scientific studies. ... on the other, has also questioned the worth of ... complementary and alternative medicine (CAM) practices. Majority of CAM ... cure. , ,The question arises as to whether ...
Cached Medicine News:Health News:Gere Jives To Bollywood Songs To Spread AIDS Awareness 2Health News:Indo-American Doctors to Build Emergency Medical System 2Health News:Is Evidence-based Medicine Enough to Support Additional Research in Alternative Medicine? 2
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
Medicine Products: